Description
CJC-1295 (Without DAC) 10 mg and CJC-1295 (With DAC 5MG) and is a research peptide supplied as a lyophilized powder in a sterile 3 mL vial. As a modified analog of Growth Hormone-Releasing Hormone (GHRH), CJC-1295 (Without DAC) is commonly utilized in laboratory research involving the GHRH receptor (GHRHR) and associated endocrine signaling pathways. The Without DAC formulation is frequently selected for studies evaluating receptor activity and peptide pharmacokinetics in laboratory settings. Each vial contains of CJC-1295 (Without DAC) 10 mg and CJC-1295 (With DAC 5MG) and is manufactured under strict quality-controlled standards to ensure consistency and integrity for laboratory and analytical research applications.
Features:
- CJC-1295 (Without DAC) 10 mg and CJC-1295 (With DAC 5MG)
- Targets the Growth Hormone-Releasing Hormone (GHRH) receptor
- Modified GHRH analog for laboratory research
- Sterile 3 mL lyophilized research vial
- Quality-controlled manufacturing
- Securely sealed for product integrity
- Suitable for laboratory and analytical research
- Clearly labeled for Research Use Only (RUO)
Research Use Only (RUO). This product is intended exclusively for laboratory research purposes. It is not intended for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease.
